Case Report
Copyright ©The Author(s) 2020.
World J Clin Cases. Jan 6, 2021; 9(1): 204-210
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.204
Table 1 Literature review of children diagnosed with myeloid neoplasm with eosinophilia and platelet-derived growth factor receptor beta rearrangement and treated with imatinib
Diagnosis
Age
Sex
Karyotype
Dose of imatinib
Duration to complete remission
Clinical character
Ref.
MDS/MPD syndrome with eosinophilia11 moFemalet(1;5)(q23;q33)-5 moAnemia, leukocytosis eosinophilia, and thrombocytopenia hepatosplenomegaly.Wilkinson et al[5]
JMMLNewbornMalet(1;5) q21;q33)370 mg/m21 moLeukocytosis with eosinophilia, thrombocytopenia and anemia hepatomegaly, Abraham et al[6]
CEL8 yrMalet(1;5)(q21; 33)200mg/m2 daily1 moAnemia and leukocytosis eosinophilia, hepatosplenomegaly.Li et al[7]
Myeloid neoplasms associated with the PDGFRB rearrangement1moMalet(1;5) (q21; 33)340 mg/m2/d---170 mg/m2/d1 moAnemia and leukocytosis eosinophils, hepatosplenomegaly.Abraham et al[8]
Myeloid neoplasms associated with the PDGFRB rearrangement4 yrMaleNot clear340 mg/m2/d---145 mg/m2/d1 moLeukocytosis; eosinophils hepatosplenomegaly.Abraham et al[8]
Myeloid neoplasms associated with the PDGFRB rearrangement19 moMalet(5;14)(q33;q32)200 mg/m2/d1 wkLeukocytosis; eosinophilia, hepatosplenomegaly.Zhang et al[9]
Myeloid neoplasms associated with the PDGFRB rearrangement1 yrFemaleNormal200 mg/m21 moLeukocytosis; anemia, eosinophilia, hepatosplenomegaly.
Myeloid neoplasms associated with the PDGFRB rearrangement2 yrFemalet(1;5)(q21;q33)200 mg/m21 moLeukocytosis; anemia, thrombocytopenia, eosinophilia, hepatosplenomegaly, fever, rashes.